0001861123-25-000001.txt : 20250228 0001861123-25-000001.hdr.sgml : 20250228 20250228160143 ACCESSION NUMBER: 0001861123-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250228 DATE AS OF CHANGE: 20250228 EFFECTIVENESS DATE: 20250228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eikon Therapeutics, Inc. CENTRAL INDEX KEY: 0001861123 ORGANIZATION NAME: IRS NUMBER: 842807586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-539574 FILM NUMBER: 25689871 BUSINESS ADDRESS: STREET 1: 3929 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: 3929 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 D 1 primary_doc.xml X0708 D LIVE 0001861123 Eikon Therapeutics, Inc. 3929 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 415-865-2050 DELAWARE None None Corporation true Roger M. Perlmutter 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Executive Officer Director Dror Berman 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Leon Chen 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Joshua Wolfe 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director James Tananbaum 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Kenneth Frazier 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Robin Washington 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Robbie Huffines 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Biotechnology Decline to Disclose 06b false 2025-02-14 false true true true false 0 399999934 350700037 49299897 false 27 0 0 0 false Eikon Therapeutics, Inc. /s/ Roger M. Perlmutter Roger M. Perlmutter CEO 2025-02-28